MDS is a bone marrow failure disorder
MDS is a blood cancer
Learn More >
For Healthcare Professionals

Additional Resources for Clinicians, Researchers, and Healthcare Professionals

Recent News

We would like to announce a clinical trial study for high risk naïve, relapsed or refractory Myelodysplastic Syndrome (MDS) patients. + Read More

MDS Centers of Excellence

Would you like your treatment center to become part of the referral system for MDS patients and be designated as a Center of Excellence? To be recognized as a Center of Excellence, an institution must have:+ Read More

Touch Oncology

European Oncology & Haematology enables time-pressured physicians to stay abreast of key advances and opinion in oncological and haematological practice in Europe.+ Read More

IPSS-R Risk Assessment Calculator

Developed by the International Working Group for the Prognosis of MDS (IWG-PM) under the aegis of the MDS Foundation, Inc.+ Read More

Review answers to commonly asked questions or get answers to your questions from an MDS expert